We built our business by obsessing over excipients

Shivang Zaveri, Director, Transchem Corporation Pharma; discusses Transchem's approach to excipients, innovation, and market strategy with Express Pharma.

- 

What differentiates Transchem in the excipients space?

We built our business by obsessing over excipients long before they became a crowded category. Our team knows how these materials behave in real formulations because we're constantly working with R&D teams and production folks, not just reading spec sheets. That lets us flag problems early, suggest smarter substitutes, and save customers from wasting batches. This along with our longstanding relationships with global producers and our reputation for clear, rapid responses, and it's no surprise we're the trusted partner in high stakes environments where precision is paramount.

How do you translate global technologies from partners like BASF for the Indian market?